We are committed to developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with serious and life-threatening conditions. Basilea is located in the Basel area, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN).
CEO David Veitch | Full-Year Report 2022
Play
News
Apr 26. 2023
Apr 18. 2023
/ Ad hoc announcement
Mar 23. 2023
Feb 14. 2023
/ Ad hoc announcement
Full-Year Report 2022
CEO Statement
For the benefit of patients around the world, we are continuing to establish Cresemba and Zevtera as truly global brands. Based on our proven expertise in advancing anti-infectives through research and development to the market, we are aiming at becoming one of the leading companies in this space.
